Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 672 entries
View as:

Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants

Phase: N/A Priority: Normal
NCT ID: NCT02166047 Org: User:
Start: 06/30/14 End: 10/20/16 Due: 10/20/17

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02607800 Org: User:
Start: 11/16/15 End: 01/11/17 Due: 01/11/18

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02081079 Org: User:
Start: 03/31/14 End: 02/28/15 Due: 02/28/16

TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada

Phase: N/A Priority: Normal
NCT ID: NCT00323492 Org: User:
Start: 09/30/05 End: 03/31/08 Due: 03/31/09

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Phase: N/A Priority: Normal
NCT ID: NCT06101329 Org: User:
Start: 11/17/23 End: 10/31/28 Due: 10/31/29

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

Phase: N/A Priority: Normal
NCT ID: NCT00128492 Org: User:
Start: 08/31/05 End: 01/31/09 Due: 01/31/10

SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada

Phase: N/A Priority: Normal
NCT ID: NCT00323687 Org: User:
Start: 09/30/04 End: 01/31/07 Due: 01/31/08

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT01672866 Org: User:
Start: 12/05/12 End: 12/29/16 Due: 12/29/17

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT06630299 Org: User:
Start: 10/08/24 End: 08/31/30 Due: 08/31/31

Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients

Phase: N/A Priority: Normal
NCT ID: NCT01399008 Org: User:
Start: 06/30/11 End: 02/29/12 Due: 02/28/13

Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02907996 Org: User:
Start: 09/09/16 End: 12/09/21 Due: 12/09/22

Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01259713 Org: User:
Start: 04/30/11 End: 01/31/14 Due: 01/31/15

Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02605954 Org: User:
Start: 11/18/15 End: 01/24/18 Due: 01/24/19

Study of Novel Antiretrovirals in Participants With HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT05585307 Org: User:
Start: 10/26/22 End: 03/18/24 Due: 03/18/25

Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01659021 Org: User:
Start: 12/04/12 End: 08/15/18 Due: 08/15/19

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Phase: N/A Priority: Normal
NCT ID: NCT04809623 Org: User:
Start: 09/01/21 End: 10/18/22 Due: 10/18/23

Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT02955602 Org: User:
Start: 11/28/16 End: 07/08/19 Due: 07/08/20

A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002206 Org: User:
Start: - End: - Due: -

Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT00113802 Org: User:
Start: 08/31/04 End: 12/31/06 Due: 12/31/07

Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults

Phase: N/A Priority: Normal
NCT ID: NCT03135028 Org: User:
Start: 05/19/17 End: 02/26/19 Due: 02/26/20

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

Phase: N/A Priority: Normal
NCT ID: NCT04150068 Org: User:
Start: 11/21/19 End: 01/31/27 Due: 01/31/28

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Phase: N/A Priority: Normal
NCT ID: NCT02073656 Org: User:
Start: 02/28/14 End: 12/31/15 Due: 12/31/16

Efficacy Study of CYT997 in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00664378 Org: User:
Start: 01/31/08 End: 02/28/11 Due: 02/28/12

Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00832572 Org: User:
Start: 01/31/09 End: 06/30/09 Due: 06/30/10

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00002161 Org: User:
Start: - End: - Due: -